Current Report Filing (8-k)

Date : 11/20/2019 @ 9:11PM
Source : Edgar (US Regulatory)
Stock : Cara Therapeutics Inc (CARA)
Quote : 17.305  0.415 (2.46%) @ 5:00AM
Cara Therapeutics share price Chart
After Hours
Last Trade
Last $ 17.33 ▲ 0.02 (0.14%)

Current Report Filing (8-k)

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) November 20, 2019

 

CARA THERAPEUTICS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

001-36279

 

75-3175693

(State or other jurisdiction
of incorporation)

 

(Commission
File Number)

 

(IRS Employer
Identification No.)

 

4 Stamford Plaza

 

 

107 Elm Street, 9th Floor

 

 

Stamford, Connecticut

 

06902

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code (203) 406-3700

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol

 

Name of each exchange on which registered

Common Stock, par value $0.001 per share

 

CARA

 

The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. x.

 

 

 


 

Item 8.01.                                                                                        Other Events.

 

The Board of Directors (the “Board”) of Cara Therapeutics, Inc. (the “Company”) adopted the Cara Therapeutics, Inc. 2019 Inducement Plan (the “Inducement Plan”), effective as of November 20, 2019.  The  Company reserved 300,000 shares of the Company’s common stock for issuance under the Inducement Plan. The only persons eligible to receive grants of Awards (as defined below) under the Inducement Plan are individuals who satisfy the standards for inducement grants in accordance with the Nasdaq Stock Market LLC listing rules, including individuals who were not previously an employee or director of the Company, or following a bona fide period of non-employment, as an inducement material to such persons entering into employment with the Company. An “Award” is any right to receive the Company’s common stock pursuant to the Inducement Plan, consisting of nonstatutory stock options, restricted stock awards, restricted stock unit awards or other stock-based awards. The Board also adopted a form of option grant notice and stock option agreement and form of restricted stock unit grant notice and restricted stock agreement (the “Related Agreements”) for use with the Inducement Plan.

 

The foregoing description of the Inducement Plan and Related Agreements is not complete and is qualified in its entirety by reference to the text of the Inducement Plan and Related Agreements, which are filed as Exhibits 10.1, 10.2 and 10.3, respectively, to this Current Report on Form 8-K.

 

Item 9.01.                                                                                        Financial Statements and Exhibits.

 

(d)                                               Exhibits

 

Exhibit No.

 

Description

 

 

 

10.1

 

Cara Therapeutics, Inc. 2019 Inducement Plan

10.2

 

Form of Stock Option Grant Notice and Stock Option Agreement under Cara Therapeutics, Inc. 2019 Inducement Plan

10.3

 

Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement under Cara Therapeutics, Inc. 2019 Inducement Plan

 

2


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

CARA THERAPEUTICS, INC.

 

 

 

 

 

By:

/s/ MANI MOHINDRU

 

 

Mani Mohindru, Ph.D.

 

 

Chief Financial Officer

 

 

(Principal Financial and Accounting Officer)

 

Date: November 20, 2019

 

3


Cara Therapeutics (NASDAQ:CARA)
Historical Stock Chart

1 Year : From Jan 2019 to Jan 2020

Click Here for more Cara Therapeutics Charts.

Cara Therapeutics (NASDAQ:CARA)
Intraday Stock Chart

Today : Tuesday 21 January 2020

Click Here for more Cara Therapeutics Charts.

Latest CARA Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20200121 06:23:01